Modulating alternative splicing of MECP2 is a potential therapeutic strategy for Rett syndrome
- Journal:
- Science Translational Medicine
- Published:
- Affiliations:
- 6
- Authors:
- 13
| Institutions | Authors | Share |
|---|---|---|
| Baylor College of Medicine (BCM), United States of America (USA) | 0.57 | |
| Texas Children's Hospital, BCM, United States of America (USA) | 0.43 |